This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Biological E Limited. Active years: 2021-2025.
Location History:
- Hyderabad, IN (2021 - 2023)
- Telangana, IN (2024)
Company Filing History:
Years Active: 2021-2025
Title: Rajendar Burki: Innovator in Vaccine Formulations and Carbohydrate Quantification
Introduction
Rajendar Burki, an inventive mind based in Hyderabad, Telangana, India, has made significant contributions to the field of biotechnology. With a total of five patents to his name, Burki has focused on developing innovative solutions that advance healthcare technologies.
Latest Patents
Among his latest patents is a breakthrough in vaccine formulations that comprises preservative systems. This invention pertains to preservative systems for vaccines that are free of thiomersal, utilizing 2-phenoxyethanol along with other preservatives such as m-cresol, benzyl alcohol, phenol, and benzoic acid. Additionally, Burki has developed a method for quantifying carbohydrates, which is a colorimetric-based approach that employs 2-phenoxyethanol as a novel reagent. This method is noted for its rapid, sensitive, simple, and direct means of carbohydrate quantification in aqueous samples.
Career Highlights
Rajendar Burki is associated with Biological E Limited, a renowned biopharmaceutical company known for its commitment to developing vaccines and therapies. His work in this organization emphasizes his role as a key contributor to advancements in vaccine technology and analytical methods in biotechnology.
Collaborations
Throughout his career, Burki has collaborated with talented coworkers such as Ramesh Venkat Matur and Narender Dev Mantena. Their collective efforts contribute to innovative research and development, further enhancing the capabilities of Biological E Limited.
Conclusion
Rajendar Burki exemplifies the spirit of innovation through his work and numerous patents. His contributions to vaccine formulations and carbohydrate quantification are critical in addressing health challenges. With ongoing collaborations and a strong foundation in biotechnology, Burki continues to be a driving force in his field.